Shanghai Mental Health Center

Shanghai, Shanghai Municipality

Oncologyliquid biopsyPhase II

Compare Sign in to watch

What changed

Study registered, no phase assigned: The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD

1w agoTrial registeredJul 6, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,072 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
NA registered
Mar 24, 2026
Pancreatic Ductal Adenocarcinoma · RECRUITING · sponsor: Mayo Clinic · A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer
ClinicalTrials.gov · NCT07324096 (opens the source filing in a new tab)
Trial
NA registered
Aug 17, 2025
Obsessive-Compulsive Disorder (OCD) · RECRUITING · sponsor: Shanghai Mental Health Center · The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder
ClinicalTrials.gov · NCT07113652 (opens the source filing in a new tab)
Trial
NA registered
Dec 14, 2024
Obsessive - Compulsive Disorder · RECRUITING · sponsor: Shanghai Mental Health Center · Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
ClinicalTrials.gov · NCT07031544 (opens the source filing in a new tab)
Trial
NA registered
Nov 10, 2024
Insomnia · RECRUITING · sponsor: Zhen Wang · Model-Driven Individualized Transcranial Direct Current Stimulation for the Treatment of Insomnia Disorders
ClinicalTrials.gov · NCT06671457 (opens the source filing in a new tab)
Trial
NA registered
Oct 20, 2024
Medical Education, Hypertension, GPT · COMPLETED · sponsor: zhen wang · AI in Hypertension Treatment Education: Comparing GPT and Traditional Methods
ClinicalTrials.gov · NCT06776354 (opens the source filing in a new tab)
Trial
NA registered
Apr 15, 2024
CVA (Cerebrovascular Accident) · RECRUITING · sponsor: Chinese University of Hong Kong · Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
ClinicalTrials.gov · NCT06241677 (opens the source filing in a new tab)
Grant
R01 · $670k · non-dilutive
Jan 1, 2024
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORDON, JEREMY WILLIAM · NCI · award ends Dec 31, 2028 · Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer
NIH RePORTER · NIH RePORTER 11251628 (opens the source filing in a new tab)
Trial
PHASE2 registered
Aug 1, 2023
Stroke, Stroke, Acute, Stroke, Ischemic, Brain Diseases · COMPLETED · sponsor: Chinese University of Hong Kong · Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
ClinicalTrials.gov · NCT05920889 (opens the source filing in a new tab)
Grant
R01 · $650k · non-dilutive
Mar 1, 2023
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORDON, JEREMY WILLIAM · NIA · award ends Dec 31, 2027 · Imaging cerebral metabolic impairment in AD using Deuterium MRI
NIH RePORTER · NIH RePORTER 11251573 (opens the source filing in a new tab)
Trial
PHASE2 registered
Nov 15, 2022
Localized Pancreatic Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma, Stage 0 Pancreatic Cancer AJCC v8, Stage I Pancreatic Cancer AJCC v8, Stage IIA Pancreatic Cancer AJCC v8 · RECRUITING · sponsor: Mayo Clinic · Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov · NCT05518903 (opens the source filing in a new tab)
Trial
PHASE2 registered
May 25, 2022
Cerebral Small Vessel Disease · RECRUITING · sponsor: Chinese University of Hong Kong · GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
ClinicalTrials.gov · NCT05356104 (opens the source filing in a new tab)
Trial
NA registered
Jul 30, 2021
Obsessive-Compulsive Disorder · COMPLETED · sponsor: Shanghai Mental Health Center · The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD
ClinicalTrials.gov · NCT04967560 (opens the source filing in a new tab)
Grant
R01 · $544k · non-dilutive
Apr 1, 2021
FRED HUTCHINSON CANCER CENTER · PI COLLISSON, ERIC · NCI · award ends Mar 31, 2027 · Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy
NIH RePORTER · NIH RePORTER 11331308 (opens the source filing in a new tab)
Trial
Study registered
Nov 5, 2020
Stroke, Acute, Stroke, Small Vessel Cerebrovascular Disease, Ischemic Stroke · COMPLETED · sponsor: Chinese University of Hong Kong · Evaluation of Small Vessel Disease by 3D-rotational Angiography
ClinicalTrials.gov · NCT04611906 (opens the source filing in a new tab)
Trial
NA registered
Nov 5, 2019
Obsessive-Compulsive Disorder · COMPLETED · sponsor: Shanghai Mental Health Center · Transcranial Direct Current Stimulation (tDCS) in the Treatment of Drug-naïve Obsessive-compulsive Disorder(OCD)
ClinicalTrials.gov · NCT04086446 (opens the source filing in a new tab)
Trial
PHASE2 registered
Jan 15, 2019
Benign Kidney Neoplasm, Kidney Neoplasm, Renal Cell Cancer · ACTIVE_NOT_RECRUITING · sponsor: Zhen Wang, MD · Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
ClinicalTrials.gov · NCT04258462 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 76%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.98name similarity 100% · shared principal investigator / founder · same city
Shared principal investigator or founder links the trial record at 0.91name similarity 100% · shared principal investigator / founder
Shared principal investigator or founder links the trial record at 0.91name similarity 100% · shared principal investigator / founder
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD
1w agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD
1w agoTrial completedSource (opens the source filing in a new tab)
Phase II trial registered: GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
6w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
6w agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer
3mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer
3mo agoTrial recruitingSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy
3mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder
4mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Evaluation of Small Vessel Disease by 3D-rotational Angiography
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Evaluation of Small Vessel Disease by 3D-rotational Angiography
4mo agoTrial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
4mo agoTrial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
4mo agoTrial registeredSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Imaging cerebral metabolic impairment in AD using Deuterium MRI
6mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer
6mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: AI in Hypertension Treatment Education: Comparing GPT and Traditional Methods
7mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: AI in Hypertension Treatment Education: Comparing GPT and Traditional Methods
7mo agoTrial completedSource (opens the source filing in a new tab)
Phase II trial registered: Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
9mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
9mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Model-Driven Individualized Transcranial Direct Current Stimulation for the Treatment of Insomnia Disorders
11mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Model-Driven Individualized Transcranial Direct Current Stimulation for the Treatment of Insomnia Disorders
11mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
Jul 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
Jul 2025Trial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Transcranial Direct Current Stimulation (tDCS) in the Treatment of Drug-naïve Obsessive-compulsive Disorder(OCD)
May 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: Transcranial Direct Current Stimulation (tDCS) in the Treatment of Drug-naïve Obsessive-compulsive Disorder(OCD)
May 2025Trial completedSource (opens the source filing in a new tab)
Phase II trial registered: Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
Mar 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
Mar 2025Trial completedSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

NA registered

NA registered

NA registered

NA registered

NA registered

NA registered

R01 · $670k · non-dilutive

PHASE2 registered

R01 · $650k · non-dilutive

PHASE2 registered

PHASE2 registered

NA registered

R01 · $544k · non-dilutive

Study registered

NA registered

PHASE2 registered